Page last updated: 2024-09-03

tyrosyl-prolyl-leucyl-glycinamide and Anochlesia

tyrosyl-prolyl-leucyl-glycinamide has been researched along with Anochlesia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kastin, AJ; Kostrzewa, RM1
Hara, C; Kastin, AJ1

Other Studies

2 other study(ies) available for tyrosyl-prolyl-leucyl-glycinamide and Anochlesia

ArticleYear
Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Brain research bulletin, 1993, Volume: 31, Issue:6

    Topics: Amino Acid Sequence; Animals; Benzazepines; Catalepsy; Drug Administration Schedule; Drug Tolerance; Male; Molecular Sequence Data; Motor Activity; MSH Release-Inhibiting Hormone; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior

1993
Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Pharmacology, biochemistry, and behavior, 1986, Volume: 24, Issue:6

    Topics: Animals; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; MSH Release-Inhibiting Hormone; Rats

1986